http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014148171-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
filingDate 2013-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014148171-A
titleOfInvention MEANS FOR PREVENTIVE AND / OR THERAPEUTIC TREATMENT OF PERIPHERAL NEUROPATHIC PAIN CAUSED BY ANTI-CANCER
abstract 1. A drug for the prophylactic and / or therapeutic treatment of peripheral neuropathic pain induced by chemotherapy, containing thrombomodulin as an active ingredient. The medicament according to claim 1, wherein thrombomodulin is a soluble thrombomodulin. The medicament according to claim 1 or 2, wherein thrombomodulin is human thrombomodulin. The medicament according to claim 1 or 2, wherein the peripheral neuropathic pain is one or more types of symptoms selected from numbness of the extremities, pain in the extremities, decreased deep reflexes of tendons, decreased muscle strength, allodynia, hyperalgesia and motor dysfunction. 5. The medicament according to claim 1 or 2, wherein the peripheral neuropathic pain is allodynia. The medicament according to claim 5, wherein allodynia is mechanical allodynia. A drug according to claim 1 or 2, wherein the anticancer drug during chemotherapy consists of one or more types of drugs selected from the group consisting of taxane drugs and a platinum preparation. The medicament according to claim 1, wherein the anticancer agent during chemotherapy is paclitaxel. The medicament according to claim 1, wherein the anticancer agent during chemotherapy is administered in accordance with FOLFOX therapy or FOLFIRI therapy. The medicament according to claim 1 or 2, wherein thrombomodulin is administered periodically. The medicament according to claim 1, which is administered to a patient with a malignant neoplasm suffering from one or more types of malignant neoplasms selected from the group consisting of ovarian cancer, non-small cell lung cancer, milk jelly cancer
priorityDate 2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454411087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7056
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07204
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15306
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431511
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5W7P8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5G2QPN5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136170999
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108180329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450144521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137231040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21824
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1MBI9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ71U07

Total number of triples: 42.